Telemedicine and remote monitoring in asthma care: innovations triggered by the pandemic

Andrea Giovanni Ledda , Ozge Can Bostan , Stefano Del Giacco

Exploration of Asthma & Allergy ›› 2025, Vol. 3 ›› Issue (1) : 100974

PDF (2302KB)
Exploration of Asthma & Allergy ›› 2025, Vol. 3 ›› Issue (1) :100974 DOI: 10.37349/eaa.2025.100974
Open Access Review
research-article
Telemedicine and remote monitoring in asthma care: innovations triggered by the pandemic
Author information +
History +
PDF (2302KB)

Abstract

Telemedicine (TM) is rapidly gaining recognition as a valuable tool for accessing medical treatments globally. The article aimed to review the latest literature on the role of TM in asthma care. It has been shown that TM offers numerous advantages for patients and clinicians, facilitating an easier access to healthcare resulting in higher patient satisfaction. Telemedicine technology, pushed by the COVID-19 pandemic, has improved asthma management, notably treatment adherence. Smart inhalers, wearable gadgets, and smartphone apps allow doctors to make data-driven decisions and empower patients to manage their diseases. Real-world research shows that TM is effective and patient-friendly. Infrastructure constraints, data security issues, and long-term patient engagement must be addressed. In conclusion, a hybrid strategy combining TM and in-person visits, enabled by AI and secure digital solutions, can provide equal, efficient, and comprehensive asthma management.

Keywords

Asthma / telemedicine / pandemic / asthma care / COVID-19

Cite this article

Download citation ▾
Andrea Giovanni Ledda, Ozge Can Bostan, Stefano Del Giacco. Telemedicine and remote monitoring in asthma care: innovations triggered by the pandemic. Exploration of Asthma & Allergy, 2025, 3 (1) : 100974 DOI:10.37349/eaa.2025.100974

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Lin CH, Cerrone DA. Shifts in Asthma Evaluation and Management During COVID-19. Curr Treat Options Allergy. 2022; 9: 42-51.

[2]

Chipps B, Zeiger RS, Beuther DA, Reibman J, Wise RA, McCann W. The Asthma Impairment and Risk Questionnaire enhances the assessment of asthma control. Ann Allergy Asthma Immunol. 2023; 131: 436-43.e1.

[3]

Davies B, Kenia P, Nagakumar P, Gupta A. Paediatric and adolescent asthma: A narrative review of telemedicine and emerging technologies for the post-COVID-19 era. Clin Exp Allergy. 2021; 51: 393-401.

[4]

Gilkey MB, Kong WY, Kennedy KL, Heisler-MacKinnon J, Faugno E, Gwinn B. Leveraging Telemedicine to Reduce the Financial Burden of Asthma Care. J Allergy Clin Immunol Pract. 2022; 10: 2536-42.

[5]

Hall K, Kafashzadeh D, Chen L, Dudovitz R, Ross MK. Trends in telemedicine visits among pediatric asthma patients during COVID-19. J Allergy Clin Immunol Glob. 2024; 3: 100239.

[6]

Hare N, Bansal P, Bajowala SS, Abramson SL, Chervinskiy S, Corriel R. Work Group Report: COVID-19: Unmasking Telemedicine. J Allergy Clin Immunol Pract. 2020; 8: 2461-73.e3.

[7]

Raidou VS, Andreadou S, Christakou A, Kortianou EA. Digital Health Care in Chronic Respiratory Diseases during and beyond the COVID-19 pandemic. A Critical Review. Med Res Arch. 2023; 11: 3887.

[8]

Smolinska S, Popescu F, Izquierdo E, Antolín-Amérigo D, Price OJ, Alvarez-Perea A. Telemedicine with special focus on allergic diseases and asthma-Status 2022: An EAACI position paper. Allergy. 2024; 79: 777-92.

[9]

Alvarez-Perea A, Dimov V, Popescu F, Zubeldia JM. The applications of eHealth technologies in the management of asthma and allergic diseases. Clin Transl Allergy. 2021; 11: e12061.

[10]

Alvarez-Perea A, Sánchez-García S, Cano RM, Antolín-Amérigo D, Tsilochristou O, Stukus DR. Impact Of “eHealth” in Allergic Diseases and Allergic Patients. J Investig Allergol Clin Immunol. 2019; 29: 94-102.

[11]

Castner J, Mammen MJ, Jungquist CR, Licata O, Pender JJ, Wilding GE. Validation of fitness tracker for sleep measures in women with asthma. J Asthma. 2019; 56: 719-30.

[12]

Liu G, Guo Y, Zhu Q, Huang B, Wang L. Estimation of respiration rate from three-dimensional acceleration data based on body sensor network. Telemed J E Health. 2011; 17: 705-11.

[13]

Greiwe J, Nyenhuis SM. Wearable Technology and How This Can Be Implemented into Clinical Practice. Curr Allergy Asthma Rep. 2020; 20: 36.

[14]

Mosnaim G, Safioti G, Brown R, DePietro M, Szefler SJ, Lang DM. Digital Health Technology in Asthma: A Comprehensive Scoping Review. J Allergy Clin Immunol Pract. 2021; 9: 2377-98.

[15]

Merchant RK, Inamdar R, Quade RC. Effectiveness of Population Health Management Using the Propeller Health Asthma Platform: A Randomized Clinical Trial. J Allergy Clin Immunol Pract. 2016; 4: 455-63.

[16]

Bocian IY, Chin AR, Rodriguez A, Collins W, Sindher SB, Chinthrajah RS. Asthma management in the digital age. Front Allergy. 2024; 5: 1451768.

[17]

Adhikari A, Hetherington A, Sur S. mmFlow: Facilitating At-Home Spirometry with 5G Smart Devices. In: 2021 18th Annual IEEE International Conference on Sensing, Communication, and Networking (SECON); 2021 6- 9; Rome, Italy. IEEE. 2021. pp. 1-9.

[18]

Kouri A, Gupta S. Mobile health (mHealth) for asthma. CHEST Pulm. 2023; 1: 100002.

[19]

Murphy J, McSharry J, Hynes L, Molloy GJ. A Smartphone App to Support Adherence to Inhaled Corticosteroids in Young Adults With Asthma: Multi-Methods Feasibility Study. JMIR Form Res. 2021; 5: e28784.

[20]

Sousa-Pinto B, Eklund P, Pfaar O, Klimek L, Zuberbier T, Czarlewski W. Validity, reliability, and responsiveness of daily monitoring visual analog scales in MASK-air®. Clin Transl Allergy. 2021; 11: e12062.

[21]

Sapouna V, Kitixis P, Petrou E, Michailidou T, Dalamarinis P, Kortianou E. Mobile health applications designed for self-management of chronic pulmonary diseases in children and adolescents: a systematic mapping review. J Bras Pneumol. 2023; 49: e20230201.

[22]

Shenoy N, Nazeran H. A PDA-based Network for Telemonitoring Asthma Triggering Gases in the El Paso School Districts of the US - Mexico Border Region. Conf Proc IEEE Eng Med Biol Soc. 2005; 2005: 5186-9.

[23]

Mosnaim GS, Greiwe J, Jariwala SP, Pleasants R, Merchant R. Digital Inhalers and Remote Patient Monitoring for Asthma. J Allergy Clin Immunol Pract. 2022; 10: 2525-33.

[24]

Portnoy JM, Waller M, De Lurgio S, Dinakar C. Telemedicine is as effective as in-person visits for patients with asthma. Ann Allergy Asthma Immunol. 2016; 117: 241-5.

[25]

Mammen JR, Java JJ, Halterman J, Berliant MN, Crowley A, Frey SM. Development and preliminary results of an Electronic Medical Record (EMR)-integrated smartphone telemedicine program to deliver asthma care remotely. J Telemed Telecare. 2021; 27: 217-30.

[26]

Huang C, Izmailova ES, Jackson N, Ellis R, Bhatia G, Ruddy M. Remote FEV1 Monitoring in Asthma Patients: A Pilot Study . Clin Transl Sci. 2021; 14: 529-35.

[27]

Reid D, Mehta J, Anis K, Mehta S. Impact of Remote Patient Monitoring Platform on Patients With Moderate to Severe Persistent Asthma: Observational Study. JMIR Form Res. 2023; 7: e51065.

[28]

Halterman JS, Fagnano M, Tremblay P, Butz A, Perry TT, Wang H. Effect of the Telemedicine Enhanced Asthma Management Through the Emergency Department (TEAM-ED) Program on Asthma Morbidity: A Randomized Controlled Trial. J Pediatr. 2024; 266: 113867.

[29]

Drake C, Lian T, Cameron B, Medynskaya K, Bosworth HB, Shah K. Understanding Telemedicine’s “New Normal”: Variations in Telemedicine Use by Specialty Line and Patient Demographics. Telemed J E Health. 2022; 28: 51-9.

PDF (2302KB)

0

Accesses

0

Citation

Detail

Sections
Recommended

/